Emerging drugs and advocacy

Ruvandhi highlights newer agents (clofazimine, bedaquiline, omadacycline) and the need for better diagnostics and patient advocacy.

Play episode from 42:09

Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!